Condition:   Esophageal Squamous Cell Carcinoma Interventions:   Drug: 1% Lugol's iodine solution;   Drug: 5% Lugol's iodine solution Sponsors:   Xijing Hospital of Digestive Diseases;   Ankang Central Hospital;   The First Affiliated Hospital of ShiheziI University;   Xi'an International Medical Center Hospital;   Air Force 986 Hospital;   Xianyang...

Conditions:   Metastatic Head-and-neck Squamous-cell Carcinoma;   Recurrent Head and Neck Squamous Cell Carcinoma Interventions:   Biological: Ficlatuzumab;   Biological: Cetuximab;   Other: Placebo Sponsor:   AVEO Pharmaceuticals, Inc. Not yet recruiting

Conditions:   Stage II Nasopharyngeal Carcinoma AJCC v8;   Stage III Nasopharyngeal Carcinoma AJCC v8;   Stage IV Nasopharyngeal Carcinoma AJCC v8 Interventions:   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Procedure: Chest Radiography;   Drug: Cisplatin;   Procedure: Computed Tomography;   Procedure: Echocardiography;   Other: Electronic Health Record Review;...

Condition:   Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Intervention:   Drug: Anlotinib Hydrochloride Capsule and Penpulimab Sponsor:   Peking Union Medical College Hospital Not yet recruiting

Condition:   Neoplasms, Head and Neck Interventions:   Drug: Dostarlimab;   Drug: Belrestotug;   Drug: GSK6097608 Sponsor:   GlaxoSmithKline Not yet recruiting

Conditions:   HPV-Related Squamous Cell Carcinoma;   HNSCC Interventions:   Biological: VB10.16;   Drug: Pembrolizumab Sponsors:   Nykode Therapeutics ASA;   Merck Sharp & Dohme LLC Recruiting